$0.2600
N/A
Last update: Nov 4, 4:00 PM

The average analyst price target for ANEBULO PHARMAC INC by Anebulo Pharmaceuticals Inc is $8, 2327.9% above the current price. The one analyst covering it rates it Speculative Buy. The latest change came on Jul 23, 2025, when Maxim Group downgraded ANEBULO PHARMAC INC by Anebulo Pharmaceuticals Inc from Buy to Hold.
Price Target Range — 2 Quarters
Analyst Consensus — 1 Analysts
Rating Trend — Last 9 Months